Contract A207_PO-0444075-V3

The University of Virginia awarded contract A207_PO-0444075-V3 to Medchemexpress LLC on August 8, 2026, for the procurement of pharmaceutical research materials. The prime contractor is obligated to deliver Epoxomicin, a specialized chemical compound, in support of the university's research operations. The contract specifies a cumulative value of $156, representing the procurement of 156 units of Epoxomicin at $1 per unit.

The contract documentation does not specify a defined performance period, county location, or designated place of performance beyond the contracting organization identified as the University of Virginia. The relatively modest contract value and unit pricing structure indicate this procurement represents a routine chemical supply purchase for institutional research purposes rather than a comprehensive service engagement. No subcontractors or performance locations outside the primary contracting organization are identified in the available contract data.